Diplomjodler ,

Where there are certainly country specific reasons, the overall train is that production had been outsourced to the lowest bidder, which is India in most cases. This means less resilient supply chains and less reliable supply.

indomara ,

Why is Australia being hit by them? I thought this was just an Australian thing... A few years ago Metformin - a diabetes drug with many generic brands was in low supply. Two years ago my birth control (the only norethisterone only pill in our market) was unavailable for 6 months out of the blue. Starting around September last year the medicated eye gel I need was unavailable, no other product in our market with those ingredients... it has only recently become available again last week. I bought 3 tubes.

To top all that off, late last year we find out that 50mg vyvanse - an adhd med my daughter and I are both on - is unavailable and won't be available til maybe the end of the January. Of course 50mg is the most common dose and our psychiatrist was away for the holidays, leading to a mad scramble for our GP to request emergency permission to prescribe and the psych to pause his holidays to write letters authorizing prescribing to dozens of GPs for his patients. We now have had to pay twice as much and drive to neighbouring towns and sometimes multiple pharmacies, to get 20mg and 30 mg.

Sphks ,
@Sphks@lemmy.dbzer0.com avatar

Yeah, it's a global shortage. We have these issues in France too.

zylinderhut ,

Same in Germany, it's like all of our medicine is produced somewhere far away or something

Sphks ,
@Sphks@lemmy.dbzer0.com avatar

In France, people were surprised because we have big historic pharma corporation, with tons of public subventions. However this shortage revealed that they make the packaging of the drugs now. The actual substances are made elsewere.

They also focus on R&D for new bankable drugs. Not the ones that are important - new ones that could make tons of money. I have a thin hope that the gouvernement will make new regulations to produce locally.

Edit. In June 2023, 210 million euros have been gifted to big pharma corps in France regarding this issue. https://www.lemonde.fr/en/france/article/2023/06/13/france-to-re-shore-production-of-50-key-medicines_6031218_7.html

  • All
  • Subscribed
  • Moderated
  • Favorites
  • random
  • globalnews@lemmy.zip
  • test
  • worldmews
  • mews
  • All magazines